RENAL DENERVATION IN THE TREATMENT OF RESISTANT HYPERTENSION: A CLINICAL CASE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper describes a case of a patient with resistant hypertension, who has successfully undergone renal denervation.

Full Text

Restricted Access

About the authors

V. Sullmov

I.M. Sechenov First Moscow State Medical University

Professor MD

A. Rodionov

I.M. Sechenov First Moscow State Medical University

Email: rodionov@mma.ru
Candidate of Medical Sciences

A. Svetankova

I.M. Sechenov First Moscow State Medical University

References

  1. Brandt M., Mahfoud F., Reda S. et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension // J. Am. Coll. Cardiol. 2012; 10: 901-9.
  2. Calhoun D., Jones D., Textor S. et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research // Circulation. 2008; 117 (25): 1403-19.
  3. Daugherty S., Powers J., Magid D. et al. Incidence and prognosis of resistant hypertension in hypertensive patients // Circulation. 2012; 125: 1635-42.
  4. Davies J., Manisty C., Petraco R. et al. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study // Int. J. Cardiol. 2013; 162 (3): 189-92.
  5. De la Sierra A., Segura J., Banegas J. et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring // Hypertension. 2011; 57: 171-4.
  6. Esler M., Krum H., Schlaich M. et al. Renal sympathetic denervation in patients with treatment resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial // Lancet. 2010; 376: 1903-9.
  7. Fagard R. Resistant hypertension // Heart. 2012; 98: 254-61.
  8. Krum H., Schlaich M., Whitbourn R. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study // Lancet. 2009; 373 (9671): 1275-81.
  9. Mahfoud F., Schlaich M., Kindermann I. et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study // Circulation. 2011; 123: 1940-4.
  10. Mancia G., Fagard R., Narkiewicz K. et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2013 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension // Eur. Heart J. doi: 10.1093/eurheartj/eht151 (in press).
  11. Mantero F., Mattarello M., Albiger N. Detecting and treating primary aldosteronism: primary aldosteronism // Exp. Clin. Endocrinol. Diab. 2007; 115: 171-4.
  12. Parati G., Lombardi C., Hedner J. et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (Co-operation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea // J. Hypertens. 2012; 30: 633-46.
  13. Persell S. Prevalence of resistant hypertension in the United States, 20032008 // Hypertension. 2011; 57: 1076-80.
  14. Pokushalov E., Romanov A., Corbucci G. et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension // J. Am. Coll. Cardiol. 2012; 60 (13): 1163-70.
  15. Redon J., Campos C., Narciso M. et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study // Hypertension. 1998; 31: 712-8.
  16. Schlaich M., Sobotka P., Krum H. et al. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept // Hypertension. 2009; 54: 1195-201.
  17. Symplicity™ Catheter (instructions for use). Medtronic, Inc., Mountain View, CA; 2010.
  18. Krum H., Barman N., Schlaich M. et al. Symplicity HTN-1 Investigators; Results presented at EuroPCR annual meeting, 2013.
  19. Witkowski A., Prejbisz A., Florczak E. et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea // Hypertension. 2011; 58 (4): 559-65.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies